28 Jun 2006 17:39
Cyprotex PLC28 June 2006 Press release 28 June 2006 Cyprotex PLC Director's Dealings Cyprotex PLC (AIM: CRX), the provider of pharmacokinetic technology andinformation, today announces that Mr Nikolas Sofronis, a non-executive Directorof the Company, bought on Tuesday 27 June 2006 40,000 ordinary shares of 0.1peach in the capital of the Company at a price of 7.11p per share. As a consequence of this purchase, the total number of shares of Cyprotex heldby Mr Sofroni represents less than 0.1% of the issued share capital. - Ends - For further information:Cyprotex PLCRobert Morrisson Atwater Tel: 016 2550 5100ir@cyprotex.com www.cyprotex.comCode Securities LimitedRichard Potts Tel: 020 7776 1200RVP@nomuracode.com www.codesecurities.com Media enquiries:AbchurchHeather Salmond / Georgina Bonham Tel: 020 7398 7700heather.salmond@abchurch-group.com www.abchurch-group.com This information is provided by RNS The company news service from the London Stock Exchange
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CRX.L Regulatory News (CRX)
CRX Share
Price
CRX Share
News
CRX Share
Chat
CRX Share
Trades
CRX
Live RNS
CRX Share
Charts
CRX Broker
Ratings
CRX Directors
Deals
CRX Financial
Diary
CRX
Fundamentals
CRX Short
Positions
CRX
Media
CRX.L Information
- There is currently no data for CRX
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Director/PDMR Shareholding
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.